Total words: 1655 | 2-word phrases: 440 | 3-word phrases: 451 | 4-word phrases: 455
Title | Try to keep the title under 60 characters (25 characters) WSJ Pro - Venture Capital |
Description | Try to keep the meta description between 50 - 160 characters (171 characters) WSJ Pro Venture Capital is a premium membership product for elite practitioners, powered by The Wall Street Journal’s peerless reporting and Dow Jones’ unrivaled data. |
Keywords | Meta keywords are not recommended anymore (171 characters) wsj pro, wsj professional, venture capital |
H1 | No H1 tag on the page (0 characters) |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | in | 11 | 3.56% | ||||||
2 | to | 10 | 3.24% | ||||||
3 | venture | 10 | 3.24% | ||||||
4 | million | 9 | 2.91% | ||||||
5 | of | 8 | 2.59% | ||||||
6 | for | 8 | 2.59% | ||||||
7 | a | 6 | 1.94% | ||||||
8 | raises | 5 | 1.62% | ||||||
9 | ai | 5 | 1.62% | ||||||
10 | funding | 4 | 1.29% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.wsj.com | Whois | wsj.com |
2 | https://www.wsj.com/pro/join/venture-capital | Whois | wsj.com |
3 | https://www.wsj.com/client/login?product=wsjpro&target=https%3A%2F%2Fwww.wsj.com%2Fpro%2Fventure-capital | Whois | wsj.com |
4 | https://www.wsj.com/pro/venture-capital?mod=nav_top_subsection | Whois | wsj.com |
5 | https://www.wsj.com/pro/venture-capital?mod=nav_top_subsection | Whois | wsj.com |
6 | https://www.wsj.com/pro/venture-capital?mod=nav_top_subsection | Whois | wsj.com |
7 | https://www.wsj.com/pro/venture-capital/newsletters?mod=nav_top_subsection | Whois | wsj.com |
8 | https://www.wsj.com/pro/join/venture-capital | Whois | wsj.com |
9 | https://www.wsj.com/client/login?product=wsjpro&target=https%3A%2F%2Fwww.wsj.com%2Fpro%2Fventure-capital | Whois | wsj.com |
10 | https://www.wsj.com/pro/venture-capital?mod=nav_top_subsection | Whois | wsj.com |
11 | https://www.wsj.com/pro/venture-capital?mod=nav_top_subsection | Whois | wsj.com |
12 | https://www.wsj.com/pro/venture-capital?mod=nav_top_subsection | Whois | wsj.com |
13 | https://www.wsj.com/pro/venture-capital/newsletters?mod=nav_top_subsection | Whois | wsj.com |
14 | https://www.wsj.com/articles/arche-capital-to-raise-100-million-debut-fund-amid-crypto-comeback-b7713428?tpl=vc&mod=hp_lead_pos1 | Whois | wsj.com |
15 | https://www.wsj.com/articles/arche-capital-to-raise-100-million-debut-fund-amid-crypto-comeback-b7713428?tpl=vc&mod=hp_lead_pos1 | Whois | wsj.com |
16 | https://www.wsj.com/articles/energy-climate-and-ai-bets-are-powering-europes-venture-sector-235290e1?tpl=vc&mod=hp_lead_pos2 | Whois | wsj.com |
17 | https://www.wsj.com/articles/energy-climate-and-ai-bets-are-powering-europes-venture-sector-235290e1?tpl=vc&mod=hp_lead_pos2 | Whois | wsj.com |
18 | https://www.wsj.com/articles/late-stage-investors-seek-to-bring-medtech-startups-to-the-home-stretch-a855dacb?tpl=vc&mod=hp_lead_pos3 | Whois | wsj.com |
19 | https://www.wsj.com/articles/late-stage-investors-seek-to-bring-medtech-startups-to-the-home-stretch-a855dacb?tpl=vc&mod=hp_lead_pos3 | Whois | wsj.com |
20 | https://www.wsj.com/articles/new-venture-firm-hopes-to-build-on-a-saudi-u-s-alignment-24d8ecd5?tpl=vc&mod=hp_lead_pos4 | Whois | wsj.com |
21 | https://www.wsj.com/articles/new-venture-firm-hopes-to-build-on-a-saudi-u-s-alignment-24d8ecd5?tpl=vc&mod=hp_lead_pos4 | Whois | wsj.com |
22 | https://www.wsj.com/articles/abbs-divisions-are-also-startup-investors-ea6f3fba?tpl=vc&mod=hp_major_commentary_pos1 | Whois | wsj.com |
23 | https://www.wsj.com/articles/abbs-divisions-are-also-startup-investors-ea6f3fba?tpl=vc&mod=hp_major_commentary_pos1 | Whois | wsj.com |
24 | https://www.wsj.com/articles/digital-health-venture-investment-rises-but-many-deals-have-yet-to-pay-off-d51a312f?tpl=vc&mod=hp_major_commentary_pos2 | Whois | wsj.com |
25 | https://www.wsj.com/articles/nato-funds-startups-aiming-to-solve-cyber-problems-in-infrastructure-2b6aaf24?tpl=vc&mod=hp_major_commentary_pos3 | Whois | wsj.com |
26 | https://www.wsj.com/articles/j2-ventures-raises-150-million-to-finance-dual-use-technologies-d9dfcea9?tpl=vc&mod=hp_major_vc_funds_pos1 | Whois | wsj.com |
27 | https://www.wsj.com/articles/j2-ventures-raises-150-million-to-finance-dual-use-technologies-d9dfcea9?tpl=vc&mod=hp_major_vc_funds_pos1 | Whois | wsj.com |
28 | https://www.wsj.com/articles/index-ventures-raising-2-3-billion-for-pair-of-fundsless-than-it-did-last-time-7b201df5?tpl=vc&mod=hp_major_vc_funds_pos2 | Whois | wsj.com |
29 | https://www.wsj.com/articles/foresite-capital-closes-900-million-life-sciences-venture-fund-17b94a8b?tpl=vc&mod=hp_major_vc_funds_pos3 | Whois | wsj.com |
30 | https://www.wsj.com/articles/heart-pump-developer-magenta-medical-raises-105-million-34c56e87?tpl=vc&mod=hp_major_life_sciences_pos1 | Whois | wsj.com |
31 | https://www.wsj.com/articles/heart-pump-developer-magenta-medical-raises-105-million-34c56e87?tpl=vc&mod=hp_major_life_sciences_pos1 | Whois | wsj.com |
32 | https://www.wsj.com/articles/obesity-telehealth-startup-form-health-raises-38-million-c4910c25?tpl=vc&mod=hp_major_life_sciences_pos2 | Whois | wsj.com |
33 | https://www.wsj.com/articles/biotech-venture-financing-hasnt-loosened-up-yet-38e001df?tpl=vc&mod=hp_major_life_sciences_pos3 | Whois | wsj.com |
34 | https://www.wsj.com/articles/greylock-leads-36-million-financing-for-cybersecurity-startup-seven-ai-048c5f09?tpl=vc&mod=hp_major_money_pos1 | Whois | wsj.com |
35 | https://www.wsj.com/articles/altrubio-gathers-funds-as-biotechs-aim-for-next-blockbuster-anti-inflammatory-therapy-12600b07?tpl=vc&mod=hp_major_money_pos2 | Whois | wsj.com |
36 | https://www.wsj.com/articles/bp-co-leads-111-million-funding-round-by-australian-green-hydrogen-electrolyzer-company-6dcd8747?tpl=vc&mod=hp_major_money_pos3 | Whois | wsj.com |
37 | https://www.wsj.com/articles/surf-air-mobility-lists-shares-giving-hope-that-a-key-venture-exit-door-is-reopening-b06c2bf4?tpl=vc&mod=hp_major_maipo_pos1 | Whois | wsj.com |
38 | https://www.wsj.com/articles/drug-developer-acelyrin-raises-540-million-in-ipo-2c2c1a40?tpl=vc&mod=hp_major_maipo_pos2 | Whois | wsj.com |
39 | https://www.wsj.com/articles/venture-capitalists-predict-more-consolidation-in-digital-health-11672870181?tpl=vc&mod=hp_major_maipo_pos3 | Whois | wsj.com |
40 | https://www.wsj.com/articles/venture-firm-narya-sees-boost-in-interest-after-co-founder-jd-vances-nomination-6db1debd?tpl=vc&mod=hp_major_people_pos1 | Whois | wsj.com |
41 | https://www.wsj.com/articles/nea-is-powering-its-ai-future-with-old-spreadsheets-powerpoint-slides-and-pdfs-06ea87c9?tpl=vc&mod=hp_major_people_pos2 | Whois | wsj.com |
42 | https://www.wsj.com/articles/smaller-drugmakers-step-up-hunt-for-acquisitions-f580fe49?tpl=vc&mod=hp_major_people_pos3 | Whois | wsj.com |
43 | https://www.wsj.com/pro/venture-capital/data/trends?mod=vc_hp_cbinsights | Whois | wsj.com |
44 | http://createsend.com/t/d-72F45EEEF97D2DA42540EF23F30FEDED | Whois | createsend.com |
45 | http://createsend.com/t/d-C0F4183E1DF49A942540EF23F30FEDED | Whois | createsend.com |
46 | http://createsend.com/t/d-988B8FE4FD88DB052540EF23F30FEDED | Whois | createsend.com |
47 | https://twitter.com/WSJVC | Whois | twitter.com |
48 | https://conferences.wsj.com/ | Whois | wsj.com |
49 | https://www.dowjones.com/products/factiva/ | Whois | dowjones.com |
50 | https://www.wsj.com/news/risk-compliance-journal | Whois | wsj.com |
51 | https://www.dowjones.com/products/risk-compliance/ | Whois | dowjones.com |
52 | https://www.dowjones.com/products/newswires/ | Whois | dowjones.com |
53 | https://www.wsj.com/news/cfo-journal | Whois | wsj.com |
54 | https://www.wsj.com/news/cio-journal | Whois | wsj.com |
55 | https://cmonetwork.wsj.com/ | Whois | wsj.com |
56 | https://www.wsj.com/news/logistics-report | Whois | wsj.com |
57 | https://www.facebook.com/wsj | Whois | facebook.com |
58 | https://twitter.com/WSJVC | Whois | twitter.com |
59 | https://www.wsj.com/podcasts/ | Whois | wsj.com |